|
C22ORF28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.12899999999716E-05 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
3.72090003253334E-09 |
| Stage1-vs-Stage2 |
5.722400E-01 |
| Stage1-vs-Stage3 |
1.124270E-02 |
| Stage1-vs-Stage4 |
9.787400E-01 |
| Stage2-vs-Stage3 |
4.155800E-02 |
| Stage2-vs-Stage4 |
6.137200E-01 |
| Stage3-vs-Stage4 |
8.986200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.40270017823241E-10 |
| Normal-vs-Asian |
2.428600E-01 |
| Caucasian-vs-AfricanAmerican |
7.650800E-01 |
| Caucasian-vs-Asian |
1.679420E-01 |
| AfricanAmerican-vs-Asian |
1.209230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
5.497800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.44999999999829E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.857100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.366800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.310800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.706600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.419800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.932600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.323600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.98220000002802E-06 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
1.62680979798324E-12 |
| Normal-vs-Grade 4 |
3.98725497063879E-12 |
| Grade 1-vs-Grade 2 |
9.956800E-01 |
| Grade 1-vs-Grade 3 |
9.216000E-01 |
| Grade 1-vs-Grade 4 |
6.443000E-01 |
| Grade 2-vs-Grade 3 |
7.525400E-01 |
| Grade 2-vs-Grade 4 |
2.948400E-01 |
| Grade 3-vs-Grade 4 |
2.646800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62525548574877E-12 |
| Normal-vs-ccB subtype |
1.62669877568078E-12 |
| ccA subtype-vs-ccB subtype |
2.309400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22044604925031E-16 |
| Normal-vs-N1 |
7.157900E-02 |
| N0-vs-N1 |
3.229800E-01 |
|
|
